These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7357815

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Pharmacokinetics of azlocillin in the burn patient].
    Drugeon HB, Pannier M, Courtieu AL.
    Presse Med; 1984 Mar 29; 13(13):805-7. PubMed ID: 6231599
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The combined action of azlocillin and sisomicin in a model simulating the in vivo serum kinetics.
    Haller I.
    Infection; 1983 Mar 29; 11 Suppl 2():S81-2. PubMed ID: 6423547
    [Abstract] [Full Text] [Related]

  • 28. Proceedings: Netherlands Society for Microbiology meeting at Utrecht on 2 May 1973. The pharmacokinetics of the new penicillins: amoxycillin and flucloxacillin, in patients with terminal renal failure undergoing haemodialysis.
    Simonian S, Oe PL, Verhoef J.
    Antonie Van Leeuwenhoek; 1973 Nov 29; 39(4):655. PubMed ID: 4543762
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [The pharmacocinetics of azlocillin (author's transl)].
    Mester U, Hartwig H, Krasemann C, Stein HJ.
    Klin Monbl Augenheilkd; 1979 Feb 29; 174(2):219-24. PubMed ID: 439698
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The effect of hemodialysis on piperacillin pharmacokinetics.
    Heim-Duthoy KL, Halstenson CE, Abraham PA, Matzke GR.
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec 29; 24(12):680-4. PubMed ID: 3818147
    [Abstract] [Full Text] [Related]

  • 35. Effect of hemodialysis on ceftazidime pharmacokinetics.
    Nikolaidis P, Tourkantonis A.
    Clin Nephrol; 1985 Sep 29; 24(3):142-6. PubMed ID: 3899438
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics of ranitidine after intravenous administration in hemodialysis patients.
    Garg DC, Baltodano N, Perez GO, Oster JR, Jallad NS, Weidler DJ.
    Pharmacology; 1985 Sep 29; 31(4):189-93. PubMed ID: 4059323
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S, Orlando R, Bertoli M, Pegoraro P, Palatini P.
    Clin Pharmacol Ther; 2006 Dec 29; 80(6):597-606. PubMed ID: 17178261
    [Abstract] [Full Text] [Related]

  • 39. Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.
    Frimodt-Möller N, Maigaard S, Toothaker RD, Bundtzen RW, Brodey MV, Craig WA, Welling PG, Madsen PO.
    Antimicrob Agents Chemother; 1980 Apr 29; 17(4):599-607. PubMed ID: 6446877
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis.
    Ahern MJ, Finkelstein FO, Andriole VT.
    Antimicrob Agents Chemother; 1976 Sep 29; 10(3):457-61. PubMed ID: 984787
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.